As of 2026-07-06, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (25.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -2075.1%.
The range of the Relative Valuation is (26.15) - (23.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.5x - 31.5x | 29.3x |
| Forward P/E multiples | 23.7x - 25.1x | 24.2x |
| Fair Price | (26.15) - (23.87) | (25.48) |
| Upside | -2127.2% - -1950.1% | -2075.1% |
| Date | P/E |